Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.



In This Section

Home / Archived Webinar Details

Who's on Your Immuno-Oncology Toxicity Team for Checkpoint Inhibitors?

Part 2 of a 3-Part Series on Cancer Immunotherapies and Care Coordination Between the Multi-Specialty Team Members

Learn why leading cancer programs are developing a toxicity team for patients on cancer immunotherapies, and how to build a toxicity team for your I-O program.

Featured Speakers:

Jarushka Naidoo, M.B.B.Ch.
Assistant Professor of Oncology, Department of Oncology
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Baltimore, MD

Laura Cappelli, MD, MHS
Assistant Professor of Medicine, Division of Rheumatology
Johns Hopkins School of Medicine
Baltimore, MD

Jennifer Mammen, MD, PhD
Assistant Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism
Johns Hopkins University School of Medicine
Baltimore, MD

Learning Objectives: 

  • Identify unique spectrum of immune-related adverse events
  • Recognize how medical specialists improve the diagnosis and rapid care for immune-related adverse events
  • Learn how to initiate and optimize an immuno-oncology toxicity team

This webinar is made possible by a charitable donation from Bristol-Myers Squibb and supported by an educational grant from Merck & Co., Inc.
View On-Demand Replay